Skip to main content
R(RM
Brand Partner

RestoreX (Path Right Medical)

PathRight Medical, Inc. is a U.S.-based medical device company headquartered in Orem, Utah. Founded in 2015, the company develops clinically researched solutions for men's sexual health and urological conditions. Its product portfolio includes RestoreX penile traction therapy, RestoreXL for post-prostatectomy length recovery, and SnipCheck post-vasectomy testing, with an emphasis on clinical evidence, physician collaboration, and patient education.

Visit Website
1,726+Total Reach
0 videos

About RestoreX (Path Right Medical)

PathRight Medical, Inc. is a privately held medical device company headquartered in Orem, Utah, specializing in men’s sexual health and urological care. Founded in 2015, the company was established to develop practical, evidence-based medical solutions for conditions that can significantly affect patients’ quality of life. Its first major product, RestoreX, was developed in cooperation with Mayo Clinic, combining physician-led innovation with a focus on clinically researched treatment options.

The company’s portfolio includes RestoreX, a penile traction therapy device designed for Peyronie’s disease and certain cases of penile length loss; RestoreXL, developed specifically for length recovery following prostate surgery; and SnipCheck, a post-vasectomy testing service. PathRight Medical also provides educational materials, product instructions, and support resources for patients and healthcare professionals. Its approach emphasizes clinical evidence, physician collaboration, ease of use, and helping patients understand available care options.

PathRight Medical serves urologists, other healthcare professionals, medical practices, and consumers seeking solutions for men’s health concerns. Through its products and clinician-focused resources, the company aims to improve access to treatment and support informed conversations about sexual health and post-surgical recovery. Its continued development of additional products reflects a broader strategy to expand beyond a single device into a portfolio of clinically focused medical technologies.